Kronos Bio Inc
NASDAQ:KRON
Balance Sheet
Balance Sheet Decomposition
Kronos Bio Inc
Current Assets | 158.4m |
Cash & Short-Term Investments | 152m |
Other Current Assets | 6.4m |
Non-Current Assets | 24.6m |
PP&E | 22m |
Other Non-Current Assets | 2.6m |
Current Liabilities | 19m |
Accounts Payable | 2.2m |
Accrued Liabilities | 8m |
Other Current Liabilities | 8.8m |
Non-Current Liabilities | 27m |
Other Non-Current Liabilities | 27m |
Balance Sheet
Kronos Bio Inc
Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | ||
---|---|---|---|---|---|---|---|
Assets | |||||||
Cash & Cash Equivalents |
10
|
33
|
248
|
198
|
76
|
64
|
|
Cash Equivalents |
10
|
33
|
248
|
198
|
76
|
64
|
|
Short-Term Investments |
0
|
60
|
165
|
141
|
162
|
109
|
|
Total Receivables |
0
|
0
|
1
|
1
|
1
|
0
|
|
Accounts Receivables |
0
|
0
|
1
|
1
|
1
|
0
|
|
Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
|
Other Current Assets |
0
|
1
|
6
|
7
|
6
|
6
|
|
Total Current Assets |
11
|
93
|
420
|
348
|
244
|
179
|
|
PP&E Net |
2
|
4
|
41
|
42
|
38
|
30
|
|
PP&E Gross |
2
|
4
|
41
|
42
|
38
|
30
|
|
Accumulated Depreciation |
0
|
0
|
1
|
3
|
6
|
7
|
|
Long-Term Investments |
0
|
5
|
49
|
0
|
10
|
2
|
|
Other Long-Term Assets |
0
|
0
|
2
|
2
|
3
|
3
|
|
Total Assets |
13
N/A
|
103
+715%
|
512
+399%
|
392
-24%
|
295
-25%
|
213
-28%
|
|
Liabilities | |||||||
Accounts Payable |
1
|
2
|
5
|
1
|
5
|
1
|
|
Accrued Liabilities |
0
|
1
|
6
|
11
|
15
|
14
|
|
Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
|
Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
|
Other Current Liabilities |
0
|
0
|
2
|
2
|
1
|
10
|
|
Total Current Liabilities |
1
|
3
|
13
|
14
|
22
|
25
|
|
Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
|
Other Liabilities |
1
|
0
|
34
|
33
|
29
|
30
|
|
Total Liabilities |
2
N/A
|
3
+58%
|
46
+1 447%
|
46
N/A
|
50
+9%
|
54
+8%
|
|
Equity | |||||||
Common Stock |
18
|
123
|
0
|
0
|
0
|
0
|
|
Retained Earnings |
7
|
24
|
112
|
263
|
396
|
509
|
|
Additional Paid In Capital |
0
|
0
|
577
|
608
|
641
|
668
|
|
Other Equity |
0
|
0
|
0
|
0
|
1
|
0
|
|
Total Equity |
11
N/A
|
100
+832%
|
466
+367%
|
345
-26%
|
245
-29%
|
159
-35%
|
|
Total Liabilities & Equity |
13
N/A
|
103
+715%
|
512
+399%
|
392
-24%
|
295
-25%
|
213
-28%
|
|
Shares Outstanding | |||||||
Common Shares Outstanding |
53
|
53
|
54
|
56
|
57
|
59
|